Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

BIO To File Court Papers In Support Of Plant Patents
Mar 3 1999
Washington, D.C. (March 3, 1999) --- The Biotechnology Industry Organization (BIO) said today it will support Pioneer HiBred International Inc. in efforts to...
Biotech President Sees More Medical Breakthroughs And Good Investment Opportunities Ahead
Feb 24 1999
NEW YORK, N.Y., (February 24, 1999) -- Twenty-one new biotechnology drugs, vaccines and new indications for existing drugs were approved by the Food and Drug...
BIO Responds To Bt Lawsuit
Feb 19 1999
  Libby Mikesell, Director of Communications at the Biotechnology Industry Organization (BIO), issued the following statement in response to reports...
Price Controls Promise Only To Undermine Biotech Drug Development
Feb 11 1999
  Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on the legislation introduced Wednesday...
Women's Health Issues Explored At BIO CEO & Investor Conference
Feb 8 1999
WASHINGTON, D.C. (Feb. 8, 1999) Among the investor sessions featured at the Biotechnology Industry Organization's (BIO) annual CEO & Investor...
52 Companies To Make Presentations At BIO's Annual CEO & Investor Conference
Jan 19 1999
WASHINGTON, D.C. (Jan. 19, 1999) Fifty-two companies will participate in the annual CEO & Investor Conference organized by the Biotechnology Industry...
BIO Statement on Iceland Genetic Data
Jan 15 1999
BIO has long been concerned about the possible misuse of genetic or medical information. Recent news reports about plans to collect data on the health...
Canada's Decision on BST Counters FDA, WHO, AMA Views
Jan 15 1999
The Biotechnology Industry Organization issued the following statement from its Executive Director, Technical Affairs, Alan Goldhammer, Ph.D.: "Health...
BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research
Nov 12 1998
(WASHINGTON, D.C., November 12, 1998). . . Carl B Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
BIO CEO & Investor Conference Presentations Target Specific Diseases, Therapies
Nov 11 1998
(WASHINGTON, D.C., November 11, 1998). . . The Biotechnology Industry Organization (BIO) will host a CEO & Investor Conference in New York Feb. 24-26,...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...